Geoffroy Durand

2.6k citations
45 papers · 1.1k indexed · h-index 18
Topics
Epigenetics and DNA Methylation (10 papers)Cancer Genomics and Diagnostics (8 papers)BRCA gene mutations in cancer (4 papers)

In The Last Decade

Geoffroy Durand

45 papers receiving 1.1k citations

Peers

Geoffroy Durand
Comparison fields: 5 of 109
  • Molecular Biology 550
  • Cancer Research 356
  • Oncology 219
  • Pulmonary and Respiratory Medicine 208
  • Genetics 190
Replace Anna Andersson with:
Anna Andersson Sweden
Yuanbo Liu China
Wangjun Yan China
Rongde Wu China
Anna C. Berardi Italy
Xiaoyan Shao China
Corinne E. Camalier United States
Jingqun Tang China
Xianzhi Lin United States
Yong Zhu China
Geoffroy Durand relative to Anna Andersson Sweden Anna Andersson's profile →
Citations per field
00.5×3.2×
Anna Andersson · 1×
Citations per year

Countries citing papers authored by Geoffroy Durand

Since Specialization
Citations

This map shows the geographic impact of Geoffroy Durand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffroy Durand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffroy Durand more than expected).

Fields of papers citing papers by Geoffroy Durand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffroy Durand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffroy Durand. The network helps show where Geoffroy Durand may publish in the future.

Co-authorship network of co-authors of Geoffroy Durand

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffroy Durand. A scholar is included among the top collaborators of Geoffroy Durand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffroy Durand. Geoffroy Durand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 1
3 4
4 4
5 3
6 16
7 20
8 12
9 16
10 6
11 14
12 37
13 12
14 16
15 47
16 16
17 20
18 104
19 19
20 44

About Geoffroy Durand

Geoffroy Durand is a scholar working on Cancer Research, Oncology and Process Chemistry and Technology, having authored 45 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cancer Genomics and Diagnostics (8 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (356 citations), Oncology (219 citations) and Molecular Biology (550 citations). Geoffroy Durand has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Florence Le Calvez‐Kelm, Zdenko Herceg, Héctor Hernández‐Vargas, Gilles Tersac, James McKay, Graham Byrnes, Fabienne Lesueur, Paul Brennan, Catherine Voegele and Maxime Vallée. Their work appears in journals such as The Lancet, Nucleic Acids Research and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026